VPValborg Vang Poulsen

Valborg Vang Poulsen

*This is an algorithmically generated author record based on publicly available information.

Valborg Vang Poulsen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis—A Literature Review

    by Valborg Vang Poulsen, Amer Hadi, Mikkel Parsberg Werge, John Gásdal Karstensen, Srdan Novovic

    Chronic pancreatitis (CP) is the end-stage of continuous inflammation and fibrosis in the pancreas evolving from acute- to recurrent acute-, early, and, finally, end-stage CP. Currently, prevention is the only way to reduce disease burden. In this setting, early detection is of great importance. Due to the anatomy and risks associated with direct sampling from pancreatic tissue, most of our information on the human pancreas arises from circulating biomarkers thought to be involved in pancreatic pathophysiology or injury. The present review provides the status of circulating biomarkers involved in the development of and progression to CP.


  • Open Access

    Pancreatic-portal vein fistula in acute pancreatitis successfully treated with endoscopic approach

    by Valborg Vang Poulsen, Annette Bøjer Jensen, Amer Hadi, Mia Prindahl Ærenlund, John Gásdal Karstensen, Srdan Novovic

    Acute pancreatitis is associated with numerous complications. Pancreatic-portal vein fistula (PPVF) is an exceptionally rare and diagnostically challenging example [1] [2]. A 63-year-old man was admitted due to abdominal pain, weight loss, newly diagnosed diabetes, and elevated liver enzymes. Contrast-enhanced computed tomography revealed acute pancreatitis with fluid exudation and a necrotic collection in the head of the pancreas, accompanied by attenuation of fluid in the portal vein. Subsequent magnetic resonance cholangiopancreatography raised suspicion of PPVF. Endoscopic retrograde cholangiopancreatography (ERCP) identified a stenosis in the pancreatic duct (PD) at the head of the pancreas, associated with an upstream fluid collection and a fistula into the portal vein. The PD was not visible as the contrast injection passed into the portal vein ([Video 1]). The therapeutic intervention included pancreatic sphincterotomy with dilation of the PD stenosis with a 6-mm balloon catheter. Two 7 cm × 7 Fr double-pigtail stents were positioned within the fluid collection. The patient developed septicemia, which was treated with antibiotics. The patient was discharged after 45 days of hospitalization. At ERCP 2 months later, no communication between the PD and portal vein was evident, but the stenosis of the PD had recurred ([Fig. 1]). The stenosis was dilated using a 4-mm balloon catheter, and one 7-Fr and one 5-Fr pancreatic stent were placed. The stents were replaced biannually during the following 12 months. There was no sign of PPVF, and the PD was patent, without stenosis. At 2.5 years’ follow-up, the patient was asymptomatic regarding acute pancreatitis and PPVF. This case highlights the importance of recognizing PPVF as a potential complication of acute pancreatitis and not solely associated with chronic pancreatitis. The patient’s long-term survival underscores the significance of tailored interventions achieving favorable outcomes in complex complications of acute pancreatitis. Endoscopy_UCTN_Code_CCL_1AZ_2AH Article published online: 25 April 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany